Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday.  His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading ->
India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July.  India’s aproval of a third COVID vaccine […] Continue reading ->
Previous infection with SARS-CoV2 induces effective immunity against future infections by 84% – but reinfection rate is still 16%, found a study published in The Lancet on Friday. This suggests that infection-induced immunity is similar to, or greater than, vaccine-associated immunity, said the authors.  The SARS-CoV2 Immunity and Reinfection Evaluation (SIREN) study involved 25,661 health […] Continue reading ->
The WHO and its member states must take swift action to enable a transparent, independent and rigorous investigation into the origins of the SARS-CoV-2 virus, said two dozen international scientists in their second open letter.  The letter – released on Wednesday by 24 scientists and researchers across Europe, the United States, and Japan – comes […] Continue reading ->
A new study published by the journal Lancet Psychiatry estimates that one in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus.  The study, conducted with researchers from both the United States and United Kingdom, analyzed the electronic health records of 236,379 COVID-19 patients primarily from […] Continue reading ->